Emerging Roles of TACE as a Key Protease in ErbB Ligand Shedding

  1. Peter J. Dempsey1,
  2. Kyle Garton2 and
  3. Elaine W. Raines2
  1. 1Pacific Northwest Research Institute, Seattle, WA 98122, USA and
  2. 2Department of Pathology, Harborview Medical Center, University of Washington, Seattle, WA, 98104, USA

Abstract

Sunnarborg et al. have published how tumor necrosis factor-α converting enzyme (TACE) can control the availability of transforming growth factor-α—a natural ligand for epidermal growth factor receptors (EGFRs)—for EGFRs located at the cell surface. Dempsey, Garton, and Raines examine the ramifications of TACE-dependent proteolytic cleavage of membrane-bound ligands on paracrine, juxtacrine, and autocrine signaling.

| Table of Contents